• Accueil >
  • Publications >
  • FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer

FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer

1 déc. 2020Annals of Nuclear Medicine

DOI : 10.1007/s12149-020-01539-7

Auteurs

Romain-David Seban, Jean-Baptiste Assie, Etienne Giroux-Leprieur, Marie-Ange Massiani, Michael Soussan, Gérald Bonardel, Christos Chouaid, Margot Playe, Lucas Goldfarb, Boris Duchemann, Nicolas Girard, Laurence Champion